NCT00198302View on ClinicalTrials.gov

Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 2005

Conditions
Staphylococcus Aureus Bacteremia
Interventions
DRUG

Aurexis®

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY